Journal
THORAX
Volume 65, Issue 11, Pages 1016-1023Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/thx.2009.132027
Keywords
-
Categories
Funding
- Karolinska Institutet
- Swedish Medical Research Council [15242-05-2]
- Torsten and Ragnar Soderbergs Foundation
- Stockholm County Council
- Mats Kleberg Foundation
- King Oscar II Jubilee Foundation
- Swedish Cancer Foundation [08 0299]
- Swedish Heart-Lung Foundation
- Swedish Society of Medicine
- Centre for Allergy Research Karolinska Institutet
- Swedish Cancer and Allergy Foundation
- Swedish Asthma and Allergy Association's Research Foundation
Ask authors/readers for more resources
Background Sarcoidosis is a systemic disease of unknown aetiology characterised by granuloma formation and the presence of interferon gamma (IFN gamma)-producing T cells that cause inflammation and tissue damage in multiple organs, especially the lung. Exosomes are nano-sized immunomodulatory vesicles of endosomal origin released from a diverse range of cells and are also found in physiological fluids including bronchoalveolar lavage fluid (BALF) from healthy individuals. Objective To investigate whether exosomes are enriched in the lungs of patients with sarcoidosis compared with healthy individuals and whether they could contribute to pathogenesis. Design BALF exosomes from patients with sarcoidosis (n = 36) and healthy controls (n = 14) were compared by electron microscopy, flow cytometry, western blot analysis and mass spectrometry. BALF exosomes were incubated with autologous peripheral blood mononuclear cells (PBMCs) or the human bronchial epithelial cell line 16HBE14o-. Cytokines were measured by ELISPOT and ELISA. Results BALF from patients with sarcoidosis showed increased levels of exosomes compared with healthy individuals. Exosomes from patients showed significantly higher expression of MHC class I and II, tetraspanins CD9, CD63 and CD81 as well as neuregulin-1, known to be associated with cancer progression. Furthermore, BALF exosomes from patients induced significantly higher IFN gamma and interleukin (IL)-13 production in autologous PBMCs compared with healthy individuals and could also stimulate IL-8 production from epithelial cells. Conclusion The results indicate for the first time a role for exosomes in human lung disease with possible contributions to the initiation and progression of inflammation in sarcoidosis. This suggests that exosomes may be a new potential target for the clinical treatment of lung diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available